Downregulation of Prdm16 Is Critical for HOXB4-Mediated Benign HSC Expansion in Vivo Hui Yu University of Tennessee Health Science Center
Total Page:16
File Type:pdf, Size:1020Kb
University of Tennessee Health Science Center UTHSC Digital Commons Theses and Dissertations (ETD) College of Graduate Health Sciences 12-2014 Downregulation of Prdm16 Is Critical for HOXB4-mediated Benign HSC Expansion In Vivo Hui Yu University of Tennessee Health Science Center Follow this and additional works at: https://dc.uthsc.edu/dissertations Part of the Medical Genetics Commons, and the Medical Molecular Biology Commons Recommended Citation Yu, Hui , "Downregulation of Prdm16 Is Critical for HOXB4-mediated Benign HSC Expansion In Vivo" (2014). Theses and Dissertations (ETD). Paper 307. http://dx.doi.org/10.21007/etd.cghs.2014.0367. This Dissertation is brought to you for free and open access by the College of Graduate Health Sciences at UTHSC Digital Commons. It has been accepted for inclusion in Theses and Dissertations (ETD) by an authorized administrator of UTHSC Digital Commons. For more information, please contact [email protected]. Downregulation of Prdm16 Is Critical for HOXB4-mediated Benign HSC Expansion In Vivo Document Type Dissertation Degree Name Doctor of Philosophy (PhD) Program Biochemistry Track Therapeutics and Cell Signaling Research Advisor Brian P. Sorrentino, MD Committee Suzanne J. Baker, PhD Wing H. Leung, MD, PhD Janet F. Partridge, PhD Lawrence M. Pfeffer, PhD DOI 10.21007/etd.cghs.2014.0367 This dissertation is available at UTHSC Digital Commons: https://dc.uthsc.edu/dissertations/307 DOWNREGULATION OF PRDM16 IS CRITICAL FOR HOXB4-MEDIATED BENIGN HSC EXPANSION IN VIVO A Dissertation Presented for The Graduate Studies Council The University of Tennessee Health Science Center In Partial Fulfillment Of the Requirements for the Degree Doctor of Philosophy From The University of Tennessee By Hui Yu December 2014 Copyright © 2014 by Hui Yu All rights reserved ii DEDICATION This dissertation is dedicated to my parents, Guoquan Yu and Yan Xu, my husband, Satish Kumar Nandakumar and my precious daughter Emma Satish for all their love and support. My lovely parents raised me and trained me to be a happy, independent and brave girl to start my own life. I can never forget the sacrifices they have made for me, especially during their most difficult times. They loved me, trained me and supported me throughout my life and encouraged me to embrace life with an optimistic attitude, no matter life is easy or tough and no matter I succeed or lose. Satish and Emma are two important people in my life. They joined my journey half way and will accompany me till the end of this adventure. We have shared all the joys and tears together. We have witnessed and will witness all the minor or major events in our life and will support each other forever. I love you both. iii ACKNOWLEDGEMENTS I would like to thank my mentor, Dr. Brian Sorrentino for giving me the opportunity to work with him. His guidance and support has been invaluable. Graduate training under his mentorship was a great experience and has prepared me for my future endeavors. I also want to thank my lab members for sharing with me their experience and advise in and out the lab. I specially would like to thank Jie Jiang, former graduate student in our lab. She helped me start my project and trained me to be independent student before she left the lab. Even now we still exchange ideas about life and work. I would also like to thank my committee members, Dr. Suzanne Baker, Dr. Janet Partridge, Dr. Wing Leung and Dr. Lawrence Pfeffer for their guidance during graduate training. Their suggestions and corrections helped shape my project which finally gets published. I would like to acknowledge the Flow Cytometry and Cell Sorting core facility and Animal Resource Center in St. Jude Children’s Research Hospital. Without their professional assistance with cell sorting and animal care this project can’t be done. iv ABSTRACT Overexpression of HOXB4 in hematopoietic stem cells (HSCs) leads to increased self-renewal without causing hematopoietic malignancies in transplanted mice. The molecular basis of HOXB4-mediated benign HSC expansion in vivo is not well understood. To gain further insight into the molecular events underlying HOXB4- mediated HSC expansion, we analyzed gene expression changes at multiple time points in Lin-Sca1+c-kit+ (LSK) cells from mice transplanted with bone marrow (BM) cells transduced with a MSCV-HOXB4-ires-YFP vector. A distinct HOXB4 transcriptional program was reproducibly induced and stabilized by 12 weeks after transplant. Dynamic expression changes were observed in genes critical for HSC self-renewal as well as genes involved in myeloid and B cell differentiation. Prdm16, a transcription factor associated with human acute myeloid leukemia (AML), was markedly repressed by HOXB4 but upregulated by HOXA9 and HOXA10, suggesting that Prdm16 downregulation was involved in preventing leukemia in HOXB4 transplanted mice. Functional evidence to support this mechanism was obtained by enforcing co-expression of sPrdm16 and HOXB4, which led to myeloid expansion, and leukemia. Before the onset of leukemia decreased HSC frequency was observed in HOXB4and sPrdm16 co-expressing cells, suggesting sustained expression of Prdm16 abolished HOXB4-mediated HSC expansion. Altogether, these studies define the transcriptional pathways involved in HOXB4 HSC expansion in vivo and identify repression of Prdm16 transcription as a mechanism by which HOXB4 mediates a benign HSC expansion. v TABLE OF CONTENTS CHAPTER 1. INTRODUCTION .....................................................................................1 Hematopoiesis ..................................................................................................................1 Adult hematopoietic hierarchy .....................................................................................1 Embryonic hematopoiesis ............................................................................................1 Hematopoietic Stem Cell .................................................................................................3 Functional characteristics of HSCs ..............................................................................3 Self-renewal ............................................................................................................ 3 Multilineage differentiation potential ..................................................................... 5 Hematopoietic stem cell characterization ....................................................................5 Cell surface antigens/receptors ............................................................................... 5 Dye exclusion.......................................................................................................... 6 Functional assay ...................................................................................................... 6 Long-term repopulating assay ............................................................................ 6 Competitive repopulation assay .......................................................................... 8 Limiting-dilution assay ....................................................................................... 8 Serial transplantation assay ................................................................................. 8 Regulation of Hematopoietic Stem Cell Pool ..................................................................8 Transcription factors ....................................................................................................9 Epigenetic regulation ...................................................................................................9 Signaling pathways ....................................................................................................10 Wnt signaling pathway ......................................................................................... 10 Notch signaling pathway....................................................................................... 11 Phosphatidylinositol 3 kinase pathway ................................................................. 11 TGF/BMP signaling pathway ............................................................................... 11 MicroRNAs ................................................................................................................12 HOX Gene Family .........................................................................................................13 HOX gene upstream regulators ..................................................................................13 Hox cofactors .............................................................................................................15 Role of Hox genes in normal hematopoiesis .............................................................15 Role of Hox genes in acute leukemia ........................................................................16 HOXB4 ..........................................................................................................................20 HOXB4 role in embryonic stem cell derived hematopoiesis .....................................20 HOXB4 overexpression enhances adult HSC self-renewal .......................................20 HOXB4 role in leukemogenesis ................................................................................21 Prdm Gene Family .........................................................................................................21 PRDM16 protein domain ...........................................................................................25